Associations between corticosteroid dosage and clinical outcomes in patients with hypoxemic COVID-19 pneumonia: A retrospective cohort study
The cumulative dexamethasone-equivalent dose during the first 14 days is not associated with in-hospital mortality in hypoxemic COVID-19 patients. However, higher cumulative doses exceeding 165 mg are associated with an increased risk of in-hospital mortality and secondary hospital-acquired infections.
Authors
- Thummaporn Naorungroj (ORCID: https://orcid.org/0000-0001-6562-4891)
- Ranistha Ratanarat (ORCID: https://orcid.org/0000-0001-7137-5537)
- Napassorn Teeratakulpisarn (ORCID: https://orcid.org/0009-0007-2068-8315)
- Supattra Chiewroongroj
Institutions
- Siriraj Hospital (TH)
- Mahidol University (TH)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1371/journal.pone.0308069
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78